Meeting slides
Suggested Readings

Cell-free DNA analysis in current cancer clinical trials: a review.

Cisneros-Villanueva M, et al. Br J Cancer. 2022;126(3):391-400.

Projected reductions in absolute cancer–related deaths from diagnosing cancers before metastasis, 2006–2015.

Clarke CA, et al. Cancer Epidemiol Biomarkers Prev. 2020;29(5):895-902.

Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?

Duffy MJ, et al. Clin Chem Lab Med. 2021;59(8):1353-1361.

New genomic technologies for multi-cancer early detection: rethinking the scope of cancer screening.

Hackshaw A, et al. Cancer Cell. 2022;40(2):109-113.

Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.

Klein EA, et al. Ann Oncol. 2021;32(9):1167-1177.

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.

Liu MC, et al. Ann Oncol. 2020;31(6):745-759.

The PATHFINDER Study: assessment of the implementation of an investigational multi-cancer early detection test into clinical practice.

Nadauld LD, et al. Cancers (Basel). 2021;13(14):3501.

Multicancer screening: one size does not fit all.

Putcha G, et al. JCO Precis Oncol. 2021:574-576.

Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.

Schrag D, et al. Lancet. 2023;402(10409):1251-1260.

Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice.

Trevethan R. Front Public Health. 2017;5:307.

Modelled mortality benefits of multi-cancer early detection screening in England.

Sasieni P, et al. Br J Cancer. 2023;129(1):72-80.

Related Activities

Hot Topics in Blood-Based Cancer Screening

Key Information on Multi-Cancer Early Detection From 2023 Spring Oncology Meetings

TOP 10 Early Cancer Detection Queries

What You Need to Know About Blood-Based Screening in Primary Care

Multi-Cancer Early Detection in Primary Care

What You Need to Know About New Blood-Based Screening Tools

Related activities
1.50 CME/CE

Can You Compete in Early Cancer Detection?

A CME Jeopardy Activity

Faculty: Mylynda B. Massart, MD, PhD; Charles P. Vega, MD, FAAFP; Richard A. Whittington, MD
Release: 10/27/2023
Expiration: 11/01/2023
1.00 CME

Can You Compete In Early Cancer Detection?

Online Activity

Faculty: Mylynda B. Massart, MD, PhD; Charles P. Vega, MD, FAAFP; Richard A. Whittington, MD
Release: 12/15/2023
Expiration: 12/15/2024